Verfahren zur Herstellung von neuen N-Phenylisopropylalkylaminen

Compounds of general formula (I) and salts thereof - where R1 = lower alkyl - R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH - R3 = H, halogen, nitro, amino, or diazonium - R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. - The p-substd. com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TOROK,SANDOR, SOMFAI,EVA, KOSA,ILDIKO, SANDOR,ILDIKO, ECSERY,ZOLTAN, KNOLL,JOZSEF
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of general formula (I) and salts thereof - where R1 = lower alkyl - R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH - R3 = H, halogen, nitro, amino, or diazonium - R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. - The p-substd. compounds are hallucinogens (10-20 times more active than mescaline), depressants or analgesics (equivalent to tetrabenazine). They are free of the latter's side effects, e.g. they are non-addicting. - The o-substd. compounds are potent and long-acting coronary dilators.